Lichen striatus

L12_LICHENSTRIA

lichen nitidus: a chronic inflammatory disease of unknown etiology characterized by 1–2 mm, discrete and uniform, shiny, flat-topped, pale flesh-colored or reddish-brown papules that may appear as hypopigmented against dark skin.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L44.2 Cause of death: ICD-10 — L44.2 2 out of 7 registries used, show all original rules.	51
4. Check minimum number of events None	51
5. Include endpoints None	51
6. Filter based on genotype QC (FinnGen only)	48

Control definitions (FinnGen only)

Control exclude: L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L44
Name in latin: Lichen striatus

NAME	L12_LICHENSTRIA
CONTROL_EXCLUDE	L12_PAPULOSQUAMOUS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L442
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L442
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Lichen striatus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	349	226	121
Only index persons	288	194	94
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.00
Median age at first event (years)
Whole population	15.40	17.57	10.72
Only index persons	23.01	27.33	14.10

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	48	40	8
Unadjusted period prevalence (%)	0.01	0.01	0.00
Median age at first event (years)	35.38	34.05	42.02

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
50: Matched controls
500

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L44.2

ICD-10 Finland

Lichen striatus

+∞

71.5

D07AC13

ATC

mometasone; topical

5.9

9.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

11.2

8.4

L43.8

ICD-10 Finland

Other lichen planus

46.5

7.0

D07AD01

ATC

clobetasol; topical

6.6

6.4

L43.9

ICD-10 Finland

Lichen planus, unspecified

+∞

6.4

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

4.60

2.46

1.1

—

(3032080) INR in Blood by Coagulation assay

165

2.20

1.95

4.2

9.7

1.04

1.17

inr

2.03

141

(40760892) CBC W Ordered Manual Differential panel - Blood

2.23

1.75

4.8

5.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

259

1.98

1.38

7.9

10.4

3.61

3.81

e9/l

0.21

223

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

2.53

1.11

1.0

1.1

0.80

0.79

g/l

—

(42870588) Differential panel, method unspecified - Blood

136

1.78

1.10

3.5

5.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.00

0.99

0.0

2.8

—

0.86

—

(4035726) Immunohistochemistry procedure

1.99

0.85

2.2

1.3

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

391

2.04

0.85

20.8

16.4

331.84

332.08

g/l

0.07

391

(3000850) Epithelial cells [#/volume] in Urine

101

1.69

0.82

4.3

2.7

10.09

7.32

e6/l

0.30

(3013512) EKG study

117

0.53

0.81

4.1

3.3

—

(36660697) Celiac disease serology panel - Serum

1.81

0.80

1.1

—

(40768804) Tissue Pathology biopsy report

156

1.60

0.79

2.8

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.77

0.79

1.6

1.7

—

(3002256) Pathology report gross observation

1.77

0.79

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

1.98

0.77

1.6

1.9

—

0.00

estimate

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.20

0.77

1.0

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

2.02

0.73

1.6

2.6

80.80

76.56

e9/l

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.87

0.68

1.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.87

0.68

9.6

4.1

25.98

24.38

mmol/l

—

(3023368) Bacteria identified in Blood by Culture

1.62

0.66

3.8

4.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

190

1.51

0.66

2.3

2.7

—

estimate

—

(40761511) CBC panel - Blood by Automated count

448

0.61

0.63

14.6

11.0

—

(40761535) Cells panel - Urine sediment

1.74

0.63

3.0

3.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.61

0.0

2.2

—

151.00

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.57

0.53

1.0

1.3

—

(3021589) Normoblasts [#/volume] in Blood

206

1.43

0.53

7.8

9.5

0.00

e9/l

-0.00

155

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

0.58

0.51

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

124

1.43

0.46

1.2

1.4

2.06

2.13

g/l

—

(3048689) Calprotectin [Mass/mass] in Stool

1.54

0.46

1.6

1.4

43.20

152.74

ug/g

—

(40768797) Stomach Pathology biopsy report

1.40

0.43

1.1

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1.46

0.43

1.2

1.3

47.60

11.03

u/ml

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.42

0.0

2.4

—

121.83

—

(3022313) Gas panel - Capillary blood

0.00

0.42

0.0

3.9

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.42

0.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.42

0.0

1.4

—

(3049717) Cytology report of Urine Cyto stain

0.00

0.41

0.0

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1.42

0.41

1.8

1.9

—

(40761536) Microorganisms panel - Urine sediment

1.47

0.40

2.4

3.1

—

(3000764) Benzodiazepines [Presence] in Urine

1.43

0.39

2.4

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.43

0.39

5.0

8.0

0.70

1.26

mmol/l

—

(3016879) Cocaine [Presence] in Urine

1.43

0.39

2.4

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1.43

0.39

2.2

9.4

122.20

122.11

g/l

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.49

0.37

1.0

2.4

379.67

351.11

nmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.69

0.35

1.1

1.4

—

(21494755) Public health laboratory ask at order entry panel

1.35

0.34

1.0

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

371

1.39

0.33

4.4

4.6

14.79

14.57

pmol/l

0.24

337

(3000494) Fungus identified in Specimen by Culture

1.32

0.31

1.3

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

434

0.80

0.28

16.1

13.9

17.00

20.47

mg/l

0.55

352

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

231

1.26

0.28

6.8

6.9

8.75

10.29

umol/l

0.68

222

(3027944) Amphetamines [Presence] in Urine

1.39

0.24

2.4

1.6

—

(3028300) Cannabinoids [Presence] in Urine

1.35

0.24

2.4

1.6

—

(3016502) Oxygen saturation in Arterial blood

1.35

0.24

2.2

9.1

97.58

96.09

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.35

0.24

6.8

7.3

—

(3027008) Opiates [Presence] in Urine

1.35

0.24

2.4

1.6

—

(3026008) Bacteria identified in Urine by Culture

133

0.78

0.23

4.4

2.8

—

(1761868) Lipid panel - Serum or Plasma

164

0.80

0.23

3.5

2.6

—

(4268621) Lupus anticoagulant assay

0.00

0.21

0.0

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

453.36

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

5.60

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.21

0.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.21

0.0

1.8

—

23.43

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

0.00

0.21

0.0

4.1

—

24.79

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.2

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

352

0.82

0.20

3.4

3.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.6

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.20

0.0

2.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.20

0.0

1.0

—

4.60

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.20

0.20

10.7

9.3

99.67

104.33

mmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

129

1.23

0.20

2.5

2.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.22

0.19

3.3

2.6

2.39

2.47

g/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.15

0.18

2.0

1.04

1.30

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.15

0.17

1.1

2.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

160

1.20

0.17

2.6

3.0

23.28

29.79

u/l

1.29

154

(3019832) Treponema pallidum Ab [Presence] in Serum

0.76

0.16

2.3

2.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

0.76

0.16

2.3

3.9

387.37

1907.37

ng/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

171

1.18

0.15

1.7

2.1

92.02

95.02

pmol/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

152

1.18

0.15

4.4

3.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

147

0.84

0.14

2.2

2.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

307

0.87

0.12

3.7

3.1

76.00

41.04

u/l

0.81

298

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

115

1.18

0.12

2.3

2.7

—

(3000492) Spirometry study

1.12

0.10

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.06

0.09

1.0

1.5

—

(40758558) Short blood count panel - Blood

147

1.13

0.08

6.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

108

1.15

0.08

2.3

2.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.87

0.08

1.6

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.87

0.07

1.4

1.7

—

(3015736) pH of Urine

189

1.10

0.06

5.0

3.3

6.50

6.34

0.17

110

(3021960) Folate [Moles/volume] in Serum or Plasma

110

1.12

0.05

1.4

1.8

22.57

23.39

nmol/l

0.07

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

150

0.91

0.05

3.1

3.5

21.71

26.69

ng/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

141

1.09

0.04

1.5

1.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

301

1.08

0.03

4.5

4.3

—

(3033658) Prothrombin time (PT) actual/Normal

107

0.92

0.02

2.6

4.3

95.10

94.50

—

107

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

147

0.93

0.02

3.8

2.4

45.21

61.21

u/l

1.62

136

(3011397) Hemoglobin [Presence] in Urine by Test strip

111

0.99

0.00

8.4

3.6

—

(36304419) Bacteria [Presence] in Urine

127

1.03

0.00

3.0

3.2

—

estimate

—

(3003694) ABO and Rh group [Type] in Blood

135

0.95

0.00

2.5

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

118

1.02

0.00

2.3

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

7.2

—

28.12

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

2.3

—

99.83

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.0

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

4.2

—

42.10

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.00

-0.00

2.4

2.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

0.00

-0.00

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

-0.00

0.0

3.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3044941) Cell count panel - Synovial fluid

0.00

-0.00

0.0

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.00

-0.00

0.0

1.0

—

1.31

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

100.71

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

3.49

—

(3018333) Ribosomal P Ab [Presence] in Serum

0.00

-0.00

0.0

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.0

—

10.46

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

0.00

-0.00

0.0

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.4

—

(3021901) Oxygen saturation in Capillary blood

0.00

-0.00

0.0

1.4

—

89.13

—

(44790048) Parainfluenza type 2 nucleic acid detection

0.00

-0.00

0.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

14.56

—

(44790047) Parainfluenza type 1 nucleic acid detection

0.00

-0.00

0.0

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3018572) Chloride [Moles/volume] in Blood

0.00

-0.00

0.0

3.9

—

104.50

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

3.4

—

83.00

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3026782) Osmolality of Urine

0.97

-0.00

1.5

2.7

549.13

567.19

mosm/kgh2o

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

0.92

-0.00

1.8

3.3

23.40

29.53

u/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.00

-0.00

0.0

1.4

—

8.03

—

(3037756) Immunofixation for Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3039000) Anion gap in Blood by calculation

0.00

-0.00

0.0

3.9

—

10.63

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3003129) Base excess in Capillary blood by calculation

0.00

-0.00

0.0

2.0

—

-1.30

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.00

-0.00

1.7

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_LICHENSTRIA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_LICHENSTRIA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_LICHENSTRIA – Lichen striatus

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Lichen striatus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints